67f93defb77a3.pdf
DOI:
Mavjud emas
1.Baio J. et al. Prevalence of Autism Spectrum Disorder among Children Aged 8 Years —Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveill Summ. 2018;67(6):1–23.2.Lord C. et al. Autism spectrum disorder. Lancet. 2020;392(10146):508–520.3.OnoreC., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012;26(3):383–392.4.Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25(1):40–45.5.Ministry of Health of the Republic of Uzbekistan. Annual Report on Pediatric Neurological Disorders, 2023.6.Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67–81.7.Meltzer A., Van de Water J. The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology. 2017;42(1):284–298.